.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Affinity Grow is stocked at 60 licensed dispensaries across Connecticut, with the deepest coverage in New Haven, Bridgeport, Danbury, Newington, and Norwalk. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Affinity Grow concentrated 58.38% of sales in Flower with year-over-year growth of 32.40% and month-over-month growth of 14.99%, while Vapor Pens held 25.41% share with a -4.69% YoY decline but a 7.25% MoM lift. Pre-Roll accounted for 11.42% share with 7.50% YoY growth contrasted by a -23.88% MoM drop, and Edible at 2.27% share fell -29.95% YoY and -13.65% MoM. Concentrates were 1.81% share with a 587.43% YoY spike but a -16.07% MoM pullback, and Tincture & Sublingual slipped -33.64% MoM to 0.59% share as Topical rose 27.76% MoM to 0.13% share. With Affinity Grow ranked 3 in Flower in Connecticut and average price up 20.15% YoY to $33.58, the mix indicates deliberate weight toward higher-priced inhalables where Flower’s momentum is offsetting softness in Edible and volatility in Pre-Roll and Concentrates.
The mix shift implies Affinity Grow’s positioning is anchored to Flower leadership (58.38% share and rank 3) and supported by selective recovery in Vapor Pens (7.25% MoM) rather than breadth across smaller formats where MoM declines of -23.88% in Pre-Roll and -16.07% in Concentrates limit diversification. The 20.15% YoY increase in average price alongside 32.40% YoY Flower growth suggests pricing power is being absorbed in core inhalables, while the -29.95% YoY contraction in Edible and the -33.64% MoM step-down in Tincture & Sublingual signal weak pull-through in non-inhalable segments. Net, July 2026 dynamics point to a strategy that solidifies share where Affinity Grow already competes at scale and rank while de-prioritizing low-share categories, with risk concentrated in a few inhalable lines that must continue to post double-digit gains to sustain overall growth.
Competitive Landscape
Affinity Grow sits at rank #3 in CT Flower in July 2026, up 1 place from #4 year over year, and improving 2 positions from #5 in April 2026; paired with competitor moves, this upward drift signals share capture from mid-pack rivals despite top-end congestion. Theraplant advanced from #6 to #2 alongside a 66.29% YoY sales increase, while Brix Cannabis (CT) slid from #2 to #4 with a 30.40% YoY sales decline, and Find. jumped from #13 to #5 with 165.16% YoY growth; in contrast, Let's Burn holds #1, constraining top-spot mobility. The pattern implies Affinity Grow’s rank trajectory is one of steady ascent driven by competitors’ volatility below #1, positioning the brand to challenge #2 if momentum continues.
Notable Products
Sunshine Daydream (3.5g) set the tone with a 26.2% month-over-month lift to rank 1, while Capy Pre-Roll 3-Pack (2.1g) advanced 42.4% to rank 3, creating a 2-position gap that concentrates momentum at the top of the chart. Flower SKUs occupy 7 of the top 10 and hold ranks 1 through 2 and 4 through 8, whereas Pre-Roll SKUs appear at ranks 3 and 9, indicating category weight skewed toward Flower despite faster percentage gains in Pre-Roll. Alien OG (3.5g) sits at rank 2 with no visible month-over-month value, keeping the leadership cluster tight even as the only cited dollar figure of $158,373 for the leader points to volume consolidation up top. The pattern implies Affinity Grow is leaning into high-velocity Flower anchors while selectively scaling Pre-Roll formats that are accelerating more quickly, positioning the mix to hedge against category volatility.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
